Form D · Biotechnology
Stealth Therapeutics, Inc.
Madison, WI · CIK 0001544817
Offering snapshot reported Aug 10, 2017 · SEC filing
- Reported sold
- $140K Offering amount: $200K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 8, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2017 | Initial | $140,000 | No comparison | 5 | SEC filing |
| Jan 15, 2016 | Initial | $65,000 | No comparison | 4 | SEC filing |
| Aug 26, 2014 | Initial | $451,916 | No comparison | 10 | SEC filing |
| Mar 16, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-292547
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None | N/A |
Source: Form D, filed Aug 10, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sam Adam | Executive |
| Sam Adams | Executive |
| Peter Drumm | Executive |
| Bradley Glenn | Director |
| Kenneth U. Johnson | Director |
| Jake Orville | Director |
| George Trutza | Director |
| George Trutzka | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
101 Nob Hill Road Suite 100
Madison, WI, 53713
Madison, WI, 53713